About this trial
It has been observed that there are negative effects on respiratory muscle strength following lobectomy. This has led to the necessity of respiratory muscle training to mitigate these adverse effects. Most studies conducted so far focus on the late postoperative period, and there are only a few studies evaluating the effectiveness of early postoperative inspiratory muscle training (IMT). It is believed that this method could be useful for facilitating patient follow-up and increasing patient motivation through visual feedback.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Volunteering to participate in the study,
Being clinically stable,
Being a lung cancer patient with a planned lobectomy with VATS,
Being between the ages of 18-65,
Disqualifiers
Having any orthopedic or neurological problem that prevents walking,
Having undergone any surgery related to the thoracic wall,
Having diseases that will affect respiratory parameters such as severe heart failure, severe chronic obstructive pulmonary disease (COPD).
Trial design
Parallel
Treatments tested in this trial
inspiratory muscle exercise
Other interventionInspiratory muscle training will be given with or without smart adaptor.
Treatment groups
Trial outcomes
Primary outcomes
Inspiratory muscle strength
Respiratory muscle strength will measure by measuring mouth pressure and using maximal inspiratory pressure (MIP) values.
Expiratory muscle strength
Respiratory muscle strength will measure by measuring mouth pressure and using maximal expiratory pressure (MEP) values.
Secondary outcomes
Functional exercise capacity
6-minute walk test (6MWT) will be used to evaluate functional exercise capacity.
Postoperative Pulmonary Complications
Postoperative pulmonary complications will be evaulate by Melbourne Group Scale. If more than 4 parameters are positive, it will be considered as having postoperative pulmonary complication.
Exercise Motivation
Exercise Motivation Attitude Scale will be used. This scale consists of 3 sub-dimensions (negative attitude and thought/positive view and health/physical appearance and health).
Dyspnea Level
Modified Borg Scale will be used to evaluate dyspnea.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: